Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue : results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis
| dc.contributor.author | Druce, Katie L. | |
| dc.contributor.author | Jones, Gareth T | |
| dc.contributor.author | Macfarlane, Gary J | |
| dc.contributor.author | Basu, Neil | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.date.accessioned | 2015-10-12T23:00:18Z | |
| dc.date.available | 2015-10-12T23:00:18Z | |
| dc.date.embargoedUntil | 2016-01-01 | |
| dc.date.issued | 2015 | |
| dc.description | Acknowledgements The authors would like to thank the University of Manchester for access to the BSRBR-RA data and the BSR staff and Steering Committee for assistance with manuscript preparation. The BSRBR-RA is supported by a research grant from the BSR to the University of Manchester, which is indirectly funded by Schering Plough, Wyeth Laboratories, Abbott Laboratories and Amgen. Funding: This work forms part of K.L.D.’s Ph.D. dissertation, which is funded by the Institute of Applied Health Sciences, University of Aberdeen. Disclosure statement: N.B. has received research support from and/or served on advisory boards for Pfizer, MSD and GSK. All other authors have declared no conflicts of interest. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 8 | |
| dc.format.extent | 109123 | |
| dc.identifier | 42756022 | |
| dc.identifier | 2293e750-854f-41b7-8f0c-cac5092d4ae7 | |
| dc.identifier | 25313148 | |
| dc.identifier | 84938539802 | |
| dc.identifier.citation | Druce, K L, Jones, G T, Macfarlane, G J & Basu, N 2015, 'Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue : results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis', Rheumatology, vol. 54, no. 6, pp. 964-971. https://doi.org/10.1093/rheumatology/keu390 | en |
| dc.identifier.doi | 10.1093/rheumatology/keu390 | |
| dc.identifier.iss | 6 | en |
| dc.identifier.issn | 1462-0324 | |
| dc.identifier.other | ORCID: /0000-0003-2322-3314/work/29064697 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/83703918 | |
| dc.identifier.uri | http://hdl.handle.net/2164/5018 | |
| dc.identifier.vol | 54 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Rheumatology | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | fatigue | en |
| dc.subject | rheumatoid arthritis | en |
| dc.subject | anti-TNF | en |
| dc.subject | RC Internal medicine | en |
| dc.subject.lcc | RC | en |
| dc.title | Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue : results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis | en |
| dc.type | Journal article | en |
